Celltrion targets $3.46 bn in sales this year on biosimilarsby The Uttam Hindu 18 March 2025 3:52 PM IST
S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilarby The Uttam Hindu 10 March 2025 1:56 PM IST
Choi reiterates efforts to make South Korea one of top 5 global bio leadersby The Uttam Hindu 26 Feb 2025 2:39 PM IST
Indian scientists find common biomarkers for early diagnosis of pancreatic and glioma cancersby The Uttam Hindu 21 Feb 2025 10:26 AM IST
Global Parkinson’s disease market to grow to $7.9 bn by 2033: Reportby The Uttam Hindu 4 Feb 2025 3:11 PM IST
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatmentby The Uttam Hindu 31 Jan 2025 2:47 PM IST
S. Korean Science ministry designates 10 technologies to innovate bio-industryby The Uttam Hindu 20 Jan 2025 3:09 PM IST
